Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,883,325
+$2,816,311 QoQ
Shares Held
189,865
+76.4% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Jun 30, 2025CallValue
$290,992
CallShares
20,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,022 across 417 Biotechnology names. DNLI ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in DNLI
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,883,325 | 189,865 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,067,014 | 107,657 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,197,672 | 193,681 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,512,677 | 104,179 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,254,048 | 89,639 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $290,992 | 20,800 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,050,647 | 77,282 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,812,452 | 88,933 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,729,392 | 93,697 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,725,733 | 74,321 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,329,345 | 64,783 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,424,191 | 66,365 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,804,151 | 135,926 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,796,966 | 162,554 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,881,611 | 125,070 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,799,000 | 64,689 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,991,379 | 64,887 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,036,730 | 69,206 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,547,321 | 110,268 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,401,704 | 143,536 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,311,384 | 164,745 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,591,312 | 147,773 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,630,678 | 116,124 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,360,607 | 123,694 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,072,384 | 85,749 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,934,374 | 79,999 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,790,024 | 159,339 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||